A. Warman

发表

Rational Design, Synthesis, and Biological Evaluation of Heterocyclic Quinolones Targeting the Respiratory Chain of Mycobacterium tuberculosis.

G. Aljayyoussi, Peter D Gibbons, G. Nixon, 2017, Journal of medicinal chemistry.

Generation of quinolone antimalarials targeting the Plasmodium falciparum mitochondrial respiratory chain for the treatment and prophylaxis of malaria

J. Hemingway, R. Sinden, M. Delves, 2012, Proceedings of the National Academy of Sciences.

Identification, Design and Biological Evaluation of Heterocyclic Quinolones Targeting Plasmodium falciparum Type II NADH:Quinone Oxidoreductase (PfNDH2)

Peter D Gibbons, G. Nixon, R. Amewu, 2012, Journal of medicinal chemistry.

Biophysical characterization of the sterol demethylase P450 from Mycobacterium tuberculosis, its cognate ferredoxin, and their interactions.

K. R. Marshall, M. Waterman, A. Munro, 2006, Biochemistry.

Cytochromes P450: novel drug targets in the war against multidrug-resistant Mycobacterium tuberculosis.

K. R. Marshall, M. Sutcliffe, N. Scrutton, 2003, Biochemical Society transactions.

A novel drug for uncomplicated malaria: targeted high throughput screening (HTS) against the type II NADH:ubiquinone oxidoreductase (PfNdh2) of Plasmodium falciparum

Peter D Gibbons, V. Barton, G. Nixon, 2010, Malaria Journal.

Biodiversity of cytochrome P450 redox systems.

D. G. Lewis, K. R. Marshall, M. Sutcliffe, 2005, Biochemical Society transactions.

Transforming rhinacanthin analogues from potent anticancer agents into potent antimalarial agents.

Wei-Chun Kao, R. Grigg, C. Hunte, 2010, Journal of medicinal chemistry.

Antitubercular pharmacodynamics of phenothiazines.

T. Rito, G. Biagini, N. Berry, 2013, The Journal of antimicrobial chemotherapy.

Cytochrome b Mutation Y268S Conferring Atovaquone Resistance Phenotype in Malaria Parasite Results in Reduced Parasite bc1 Catalytic Turnover and Protein Expression

H. Ranson, G. Biagini, S. Ward, 2012, The Journal of Biological Chemistry.

Identification of 2-Aryl-Quinolone Inhibitors of Cytochrome bd and Chemical Validation of Combination Strategies for Respiratory Inhibitors against Mycobacterium tuberculosis

N. Fotouhi, J. Bibby, G. Aljayyoussi, 2023, ACS infectious diseases.

Identification, Design and Biological Evaluation of Bisaryl Quinolones Targeting Plasmodium falciparum Type II NADH:Quinone Oxidoreductase (PfNDH2)

Peter D Gibbons, G. Nixon, R. Amewu, 2012, Journal of medicinal chemistry.

Chapter 17 Type II NADH: quinone oxidoreductases of Plasmodium falciparum and Mycobacterium tuberculosis kinetic and high-throughput assays.

Nicholas Fisher, G. Biagini, S. Ward, 2009, Methods in enzymology.

Biodiversity of cytochrome P 450 redox systems

D. G. Lewis, K. R. Marshall, M. Sutcliffe, 2005 .

Characterization of Cupriavidus metallidurans CYP116B1 – A thiocarbamate herbicide oxygenating P450–phthalate dioxygenase reductase fusion protein

K. R. Marshall, A. Munro, K. J. McLean, 2012, The FEBS journal.

The molecular enzymology of cytochromes P450 of biotechnological and medical interest

Ashley James Warman, A. Warman, 2007 .

Identification of Novel Antimalarial Chemotypes via Chemoinformatic Compound Selection Methods for a High-Throughput Screening Program against the Novel Malarial Target, PfNDH2: Increasing Hit Rate via Virtual Screening Methods

Paul Stocks, Paul M. O'Neill, Neil G. Berry, 2012, Journal of medicinal chemistry.

Flavocytochrome P450 BM3: an update on structure and mechanism of a biotechnologically important enzyme.

A W Munro, A J Warman, O Roitel, 2005, Biochemical Society transactions.

Rational Design, Synthesis, and Biological Evaluation of Heterocyclic Quinolones Targeting the Respiratory Chain of Mycobacterium tuberculosis.

G. Aljayyoussi, Peter D Gibbons, G. Nixon, 2017, Journal of medicinal chemistry.

Antitubercular pharmacodynamics of phenothiazines.

T. Rito, G. Biagini, N. Berry, 2013, The Journal of antimicrobial chemotherapy.